Interpretation of methamphetamine and amphetamine enantiomer data

Area of Science:

• Forensic Toxicology
• Analytical Chemistry

Background:

• Interpreting drug test results, especially for methamphetamine, presents significant challenges due to potential legitimate uses.
• Methamphetamine is a Schedule II controlled substance, but its l-enantiomer is present in over-the-counter products like Vick's Inhaler.
• This ambiguity complicates determining illicit versus legitimate methamphetamine use from standard drug screens.

Purpose of the Study:

• To address the challenges in interpreting methamphetamine drug test results.
• To establish a method for unambiguously distinguishing illicit methamphetamine use from use of exempt products.

Main Methods:

• Evaluation of experimental and published data on methamphetamine and amphetamine enantiomeric distributions in urine.
• Analysis of enantiomeric characterization of methamphetamine and amphetamine.
• Focus on the utility of amphetamine enantiomeric distribution for interpretation.

Main Results:

• Identification of methamphetamine and amphetamine in urine does not definitively prove controlled substance use.
• Enantiomeric characterization of methamphetamine alone may yield equivocal results.
• The enantiomeric distribution of amphetamine provides unambiguous interpretation.

Conclusions:

• Detection of the d-enantiomer or a mixture of d- and l-enantiomers of methamphetamine clearly indicates illicit use.
• The l-enantiomer is the sole form found in Vick's Inhaler, making its detection consistent with legitimate use.
• Detecting specific enantiomers is crucial for forensic toxicology and legal implications.